The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder characterized pathologically by ubiquitinated TAR DNA binding protein (TDP-43) inclusions. The function of TDP-43 in the nervous system is uncertain, and a mechanistic role in neurodegeneration remains speculative. We identified neighboring mutations in a highly conserved region of TARDBP in sporadic and familial ALS cases. TARDBPM337V segregated with disease within one kindred and a genome-wide scan confirmed that linkage was restricted to chromosome 1p36, which contains the TARDBP locus. Mutant forms of TDP-43 fragmented in vitro more readily than wild type and, in vivo, caused neural apoptosis and developmental delay in the chick embryo. Our evidence suggests a pathophysiological link between TDP-43 and ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in TARDBP, which encodes the transactive response DNA binding protein 43 kDa (TDP-43), are the third most common cause of familial autosomal dominant ALS and account for rare cases of sporadic ALS [290–293].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [291]
In the citing paper
“while mutations in TARDBP (encoding TAR DNA- binding protein 43 [TDP43])306 and FUS (encoding the fused in sarcoma protein) have a lower frequency (<5%).307”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“emphasizing that microglia in the late stage accelerate disease progression.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“and mutations in TARDBP, the gene encoding TDP-43, have been identified in patients with ALS or FTD,306,333 indicating a mechanistic link between TDP-43 and ALS/FTD and also suggesting a common underlying mechanism”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“Reduced mutant levels in microglia did not have much effect on early disease progression, but substantially slowed it later on,306”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2
Hadano, S., Hand, C. K., Osuga, H., Yanagisawa, Y., Otomo, A., Devon, R. S., Miyamoto, N., Showguchi-Miyata, J., Okada, Y., Singaraja, R. R., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-166 · Cited by 676
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
Buratti, E. (2007) · Frontiers in bioscience · doi:10.2741/2727 · Cited by 493
Self-citationTDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail
Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S. G., Ayala, Y. M., & Baralle, F. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505557200 · Cited by 474
Self-citationCo-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Nakashima-Yasuda, H., Uryu, K., Robinson, J., Xie, S. X., Hurtig, H., Duda, J. E., Arnold, S. E., Siderowf, A., Grossman, M., Leverenz, J. B., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0261-2 · Cited by 468
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,011
Kim, S. H., Shi, Y., Hanson, K. A., Williams, L. M., Sakasai, R., Bowler, M. J., & Tibbetts, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808064200 · Cited by 120
Sumoylation in neurodegenerative diseases
Krumova, P., & Weishaupt, J. H. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1158-3 · Cited by 120
Tanaka, Y., Matsuwaki, T., Yamanouchi, K., & Nishihara, M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.032 · Cited by 120
Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis
Vass, R., Ashbridge, E., Geser, F., Hu, W. T., Grossman, M., Clay-Falcone, D., Elman, L., McCluskey, L., Lee, V. M. Y., Van Deerlin, V. M., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0782-y · Cited by 119
Protein Kinase CK-1 Inhibitors As New Potential Drugs for Amyotrophic Lateral Sclerosis
Salado, I. G., Redondo, M., Bello, M. L., Pérez, C., Liachko, N. F., Kraemer, B. C., Miguel, L., Lecourtois, M., Gil, C., Martínez, A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500065f · Cited by 119
The genetics of amyotrophic lateral sclerosis: current insights
Kirby, J., Sultan, A. A., Waller, R., & Heath, P. R. (2016) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s84956 · Cited by 119
TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2
Aizawa, H., Sawada, J., Hideyama, T., Yamashita, T., Katayama, T., Hasebe, N., Kimura, T., Yahara, O., & Kwak, S. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0678-x · Cited by 119
Autophagy as a common pathway in amyotrophic lateral sclerosis
Nguyen, D. K. H., Thombre, R., & Wang, J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.006 · Cited by 118
Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration
Audano, M., Schneider, A., & Mitro, N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14471 · Cited by 118
The involvement of stress granules in aging and aging‐associated diseases
Cao, X., Jin, X., & Liu, B. (2020) · Aging Cell · doi:10.1111/acel.13136 · Cited by 118
Acevedo‐Arozena, A., Kalmár, B., Essa, S., Ricketts, T., Joyce, P. I., Kent, R., Rowe, C. E., Parker, A., Gray, A. L., Hafezparast, M., et al. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007237 · Cited by 120
A90V TDP‐43 variant results in the aberrant localization of TDP‐43 in vitro
Winton, M. J., Deerlin, V. M. V., Kwong, L. K., Yuan, W., McCarty-Wood, E., Yu, C., Schellenberg, G. D., Rademakers, R., Caselli, R. J., Karydas, A., et al. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.05.024 · Cited by 118
Cytoplasmic dynein in neurodegeneration
Eschbach, J., & Dupuis, L. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.004 · Cited by 117
Xia, Q., Hu, Q., Wang, H., Yang, H., Gao, F., Ren, H., Chen, D., Fu, C., Zheng, L. P., Zhen, X., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.69 · Cited by 117
miRNAs at the interface of cellular stress and disease
Emde, A., & Hornstein, E. (2014) · The EMBO Journal · doi:10.15252/embj.201488142 · Cited by 118
Kim, C., Kang, D., Lee, E. K., & Lee, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2062384 · Cited by 117
Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations
Konopka, A., Whelan, D. R., Jamali, M. S., Perri, E. R., Shahheydari, H., Toth, R. P., Parakh, S., Robinson, T., Cheong, A., Mehta, P. M., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00386-4 · Cited by 117
Self-citationAmyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement
Rojas, P., Ramirez, A. I., Fernández‐Albarral, J. A., López‐Cuenca, I., Salobrar‐García, E., Cadena, M., Elvira‐Hurtado, L., Salazar, J. J., de Hoz, R., & Ramirez, J. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.566858 · Cited by 117
RNA splicing: disease and therapy
Douglas, A. G. L., & Wood, M. J. A. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr020 · Cited by 117
Neuropathology of non-Alzheimer degenerative disorders.
(2009) · PubMed Central · Cited by 117
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
Shepheard, S. R., Parker, M. D., Cooper-Knock, J., Verber, N. S., Tuddenham, L., Heath, P., Beauchamp, N., Place, E., Sollars, E. S. A., Turner, M. R., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325014 · Cited by 116
Natural isothiocyanates: Genotoxic potential versus chemoprevention
Fimognari, C., Turrini, E., Ferruzzi, L., Lenzi, M., & Hrelia, P. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.12.001 · Cited by 116
What causes amyotrophic lateral sclerosis?
Martin, S., Al Khleifat, A., & Al-Chalabi, A. (2017) · F1000Research · doi:10.12688/f1000research.10476.1 · Cited by 107
Self-citationQuantitative analysis of cryptic splicing associated with TDP-43 depletion
Humphrey, J., Emmett, W., Fratta, P., Isaacs, A. M., & Plagnol, V. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0274-1 · Cited by 116
Praveenraj, S. S., Sonali, S., Anand, N., Hediyal, T. A., Vichitra, C., Kalyan, M., Kanna, P. V., Chandana, K. A., Paneyala, S., Mahalakshmi, A. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02990-5 · Cited by 116
The genetics of amyotrophic lateral sclerosis
Nijs, M., & Damme, P. V. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001294 · Cited by 120
Translational potential of astrocytes in brain disorders
Verkhratsky, A., Steardo, L., Parpura, V., & Montana, V. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.003 · Cited by 115
Gidalevitz, T., Kikis, E. A., & Morimoto, R. I. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.11.001 · Cited by 114
Protein folding alterations in amyotrophic lateral sclerosis
Parakh, S., & Atkin, J. D. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.010 · Cited by 115
Shelkovnikova, T. A., Kukharsky, M. S., An, H., Dimasi, P., Alexeeva, S., Shabir, O., Heath, P. R., & Buchman, V. L. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0263-7 · Cited by 115
Inflammation Induces TDP-43 Mislocalization and Aggregation
Correia, A. S., Patel, P., Dutta, K., & Julien, J.-P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140248 · Cited by 114
Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP‐43
Urushitani, M., Sato, T., Bamba, H., Hisa, Y., & Tooyama, I. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22243 · Cited by 114
Mutant TDP-43 and FUS Cause Age-Dependent Paralysis and Neurodegeneration in C. elegans
Vaccaro, A., Tauffenberger, A., Aggad, D., Rouleau, G. A., Drapeau, P., & Parker, J. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031321 · Cited by 114
Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases
Tanna, T., & Sachan, V. (2014) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666140923101110 · Cited by 114
Methylene blue and dimebon inhibit aggregation of TDP‐43 in cellular models
Yamashita, M., Nonaka, T., Arai, T., Kametani, F., Buchman, V. L., Ninkina, N. N., Бачурин, С. О., Akiyama, H., Goedert, M., & Hasegawa, M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.042 · Cited by 114
Metabolism and mis-metabolism of the neuropathological signature protein TDP-43
Huang, C.-C. S., Bose, J. K., Majumder, P., Lee, K., Huang, J.-T. J., Huang, J. K., & Shen, C.-K. J. (2014) · Journal of Cell Science · doi:10.1242/jcs.136150 · Cited by 115
Hatzipetros, T., Bogdanik, L. P., Tassinari, V. R., Kidd, J. D., Moreno, A. J., Davis, C., Osborne, M. A., Austin, A., Vieira, F. G., Lutz, C. M., et al. (2013) · Brain Research · doi:10.1016/j.brainres.2013.10.013 · Cited by 113
Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis
McGurk, L., Mojsilovic‐Petrovic, J., Deerlin, V. M. V., Shorter, J., Kalb, R. G., Lee, V. M., Trojanowski, J. Q., Lee, E. B., & Bonini, N. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0586-1 · Cited by 115
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Xiang, Y., Song, X., & Long, D. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03660-8 · Cited by 116
Pallidonigral TDP-43 pathology in Perry syndrome
Wider, C. W., Dickson, D. W., Stoessl, A. J., Tsuboi, Y., Chapon, F., Gutmann, L., Lechevalier, B., Calne, D. B., Personett, D. A., Hulihan, M., et al. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.07.005 · Cited by 113
Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives
Beleza‐Meireles, A., & Al‐Chalabi, A. (2009) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802585469 · Cited by 113
Self-citationNakaya, T., Alexiou, P., Maragkakis, M., Chang, A., & Mourelatos, Z. (2013) · RNA · doi:10.1261/rna.037804.112 · Cited by 112
Can Parkinson's disease pathology be propagated from one neuron to another?
Dunning, C. J. R., Reyes, J. F., Steiner, J. A., & Brundin, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.11.003 · Cited by 111
Haenig, C., Atias, N., Taylor, A. K., Mazza, A., Schaefer, M. H., Russ, J., Riechers, S., Jain, S., Coughlin, M., Fontaine, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108050 · Cited by 112
Stress granules at the intersection of autophagy and ALS
Monahan, Z. T., Shewmaker, F. P., & Pandey, U. B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.022 · Cited by 110
Role of FET proteins in neurodegenerative disorders
Svetoni, F., Frisone, P., & Paronetto, M. P. (2016) · RNA Biology · doi:10.1080/15476286.2016.1211225 · Cited by 110
Sirtuins in Neuroendocrine Regulation and Neurological Diseases
Fujita, Y., & Yamashita, T. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00778 · Cited by 110
Nuclear RNA binding regulates TDP-43 nuclear localization and passive nuclear export
Duan, L., Zaepfel, B. L., Aksenova, V., Dasso, M., Rothstein, J. D., Kaláb, P., & Hayes, L. R. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111106 · Cited by 110
Janssens, J., Wils, H., Kleinberger, G., Joris, G., Cuijt, I., Groote, C. C., Broeckhoven, C. V., & Kumar‐Singh, S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8427-5 · Cited by 110
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders
Bhat, A., Ray, B., Mahalakshmi, A. M., Tuladhar, S., Nandakumar, D., Srinivasan, M., Essa, M. M., Chidambaram, S. B., Guillemin, G. J., & Sakharkar, M. K. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105078 · Cited by 109
Molecular analysis and biochemical classification of TDP-43 proteinopathy
Tsuji, H., Arai, T., Kametani, F., Nonaka, T., Yamashita, M., Masuda‐Suzukake, M., Hosokawa, M., Yoshida, M., Hatsuta, H., Takao, M., et al. (2012) · Brain · doi:10.1093/brain/aws230 · Cited by 109
Fazal, R., Boeynaems, S., Swijsen, A., De Decker, M., Fumagalli, L., Moisse, M., Vanneste, J., Guo, W., Boon, R., Vercruysse, T., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106177 · Cited by 108
Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats
Huang, C., Tong, J., Bi, F., Zhou, H., & Xia, X. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59130 · Cited by 108
The wobbler mouse, an ALS animal model
Moser, J., Bigini, P., & Schmitt‐John, T. (2013) · Molecular Genetics and Genomics · doi:10.1007/s00438-013-0741-0 · Cited by 108
Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
Webster, C. P., Smith, E. F., Shaw, P. J., & Vos, K. J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00123 · Cited by 109
Bo, R. D., Ghezzi, S., Corti, S. P., Pandolfo, M., Ranieri, M., Santoro, D., Ghione, I., Prelle, A. C., Orsetti, V., Mancuso, M., et al. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02574.x · Cited by 108
Scaramuzzino, C., Monaghan, J., Milioto, C., Lanson, N. A., Maltare, A., Aggarwal, T., Casci, I., Fackelmayer, F. O., Pennuto, M., & Pandey, U. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061576 · Cited by 108
The distinct genetic pattern of ALS in Turkey and novel mutations
Özoğuz, A., Uyan, Ö., Birdal, G., Tunca, C., Kartal, E., Lahut, S., Ömür, Ö., Ağım, Z. S., Eken, A. G., Şen, N.-E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.032 · Cited by 108
Sabatelli, M., Moncada, A., Conte, A., Lattante, S., Marangi, G., Luigetti, M., Lucchini, M., Massimiliano Mirabella, A., Romano, Â., Grande, A. D., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt328 · Cited by 107
Fogarty, M. J., Klenowski, P. M., Lee, J. D., Drieberg-Thompson, J. R., Bartlett, S. E., Ngo, S. T., Hilliard, M. A., Bellingham, M. C., & Noakes, P. G. (2016) · Scientific Reports · doi:10.1038/srep37968 · Cited by 107
van der Zee, J., Gijselinck, I., Mossevelde, S. V., Perrone, F., Dillen, L., Heeman, B., Bäumer, V., Engelborghs, S., Bleecker, J. D., Baets, J., et al. (2016) · Human Mutation · doi:10.1002/humu.23161 · Cited by 107
Ciryam, P., Lambert-Smith, I. A., Bean, D. M., Freer, R., Cid, F., Tartaglia, G. G., Saunders, D. N., Wilson, M. R., Oliver, S. G., Morimoto, R. I., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613854114 · Cited by 107
Humphrey, J., Birsa, N., Milioto, C., McLaughlin, M., Ule, A. M., Robaldo, D., Eberle, A. B., Kräuchi, R., Bentham, M. P., Brown, A., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa410 · Cited by 107
Focusing on mitochondria in the brain: from biology to therapeutics
Song, N., Mei, S., Wang, X.-X., Hu, G., & Lu, M. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00409-w · Cited by 111
Methylene Blue Protects against TDP-43 and FUS Neuronal Toxicity in C. elegans and D. rerio
Vaccaro, A., Patten, S. A., Ciura, S., Maios, C., Therrien, M., Drapeau, P., Kabashi, E., & Parker, J. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042117 · Cited by 107
Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy
Caillet‐Boudin, M., Fernández-Gómez, F.-J., Tran, H., Dhaenens, C., Buée, L., & Sergeant, N. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00057 · Cited by 107
Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation
Tateishi, T., Hokonohara, T., Yamasaki, R., Miura, S., Kikuchi, H., Iwaki, A., Tashiro, H., Furuya, H., Nagara, Y., Ohyagi, Y., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0621-1 · Cited by 106
Sun, M., Bell, W., LaClair, K. D., Ling, J. P., Han, H., Kageyama, Y., Pletniková, O., Troncoso, J. C., Wong, P. C., & Chen, L. L. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1701-2 · Cited by 106
SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells
Peggion, C., Scalcon, V., Massimino, M. L., Nies, K., Lopreiato, R., Rigobello, M. P., & Bertoli, A. (2022) · Antioxidants · doi:10.3390/antiox11040614 · Cited by 106
Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy
Wang, H., Guan, L., & Deng, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1170996 · Cited by 108
Humoral factors in ALS patients during disease progression
Ehrhart, J. C., de Smith, A. J., Kuzmin‐Nichols, N., Zesiewicz, T., Jahan, I., Shytle, R. D., Kim, S.-H., Sanberg, C. D., Vu, T., Gooch, C. L., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0350-4 · Cited by 106
Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease
Fujishiro, H., Uchikado, H., Arai, T., Hasegawa, M., Akiyama, H., Yokota, O., Tsuchiya, K., Togo, T., Iseki, E., & Hirayasu, Y. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0463-2 · Cited by 106
Aronica, E., Baas, F., Iyer, A. M., ten Asbroek, A. L. M. A., Morello, G., & Cavallaro, S. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.002 · Cited by 106
Xia, R., Liu, Y., Yang, L., Gál, J., Zhu, H., & Jia, J. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-10 · Cited by 106
Vinceti, M., Bottecchi, I., Fan, A. M., Finkelstein, Y., & Mandrioli, J. (2012) · Reviews on Environmental Health · doi:10.1515/reveh-2012-0002 · Cited by 106
Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis
Yamashita, S., & Ando, Y. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0036-y · Cited by 105
Ludolph, A. C., Brettschneider, J., & Weishaupt, J. H. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328356d328 · Cited by 105
PolyQ Repeat Expansions in ATXN2 Associated with ALS Are CAA Interrupted Repeats
Yu, Z., Zhu, Y., Chen‐Plotkin, A. S., Clay-Falcone, D., McCluskey, L. F., Elman, L. B., Kalb, R. G., Trojanowski, J. Q., Lee, V. M. ‐., Deerlin, V. M. V., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017951 · Cited by 105
Sun, Y., & Chakrabartty, A. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01088 · Cited by 105
The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
Doty, K. R., Guillot-Sestier, M.-V., & Town, T. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.008 · Cited by 104
Pathophysiological insights into ALS with C9ORF72 expansions
Williams, K. L., Fifita, J. A., Vucic, S., Durnall, J. C., Kiernan, M. C., Blair, I. P., & Nicholson, G. A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304529 · Cited by 104
Self-citationTanikawa, C., Ueda, K., Suzuki, A., Iida, A., Nakamura, R., Atsuta, N., Tohnai, G., Sobue, G., Saichi, N., Momozawa, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.031 · Cited by 104
Axon-Seq Decodes the Motor Axon Transcriptome and Its Modulation in Response to ALS
Nijssen, J., Benitez, J. A., Hoogstraaten, R. I., Kee, N., & Hedlund, E. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.11.005 · Cited by 104
Walker, A. K., & Atkin, J. D. (2011) · IUBMB Life · doi:10.1002/iub.520 · Cited by 104
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Cohen, J., Mathew, A., Dourvetakis, K. D., Sanchez-Guerrero, E., Pangeni, R. P., Gurusamy, N., Aenlle, K. K., Ravindran, G., Twahir, A., Isler, D., et al. (2024) · Cells · doi:10.3390/cells13060511 · Cited by 103
Association of Long ATXN2 CAG Repeat Sizes With Increased Risk of Amyotrophic Lateral Sclerosis
Daoud, H., Belzil, V., Martins, S., Sabbagh, M., Provencher, P., Lacomblez, L., Meininger, V., Camu, W., Dupré, N., Dion, P. A., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.111 · Cited by 103
Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS
Callister, J. B., & Pickering-Brown, S. M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.001 · Cited by 103
Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis
Sundaramoorthy, V., Walker, A. K., Tan, V. X., Fifita, J. A., McCann, E. P., Williams, K. L., Blair, I. P., Guillemin, G. J., Farg, M. A., & Atkin, J. D. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv126 · Cited by 103
Self-citationTargeted next-generation sequencing assay for detection of mutations in primary myopathies
Evilä, A., Arumilli, M., Udd, B., & Hackman, P. (2015) · Neuromuscular Disorders · doi:10.1016/j.nmd.2015.10.003 · Cited by 103
Splicing repression is a major function of TDP-43 in motor neurons
Donde, A., Sun, M., Ling, J. P., Braunstein, K. E., Pang, B., Wen, X., Cheng, X., Chen, L., & Wong, P. C. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02042-8 · Cited by 109
Giannini, M., Bayona‐Feliú, A., Sproviero, D., Barroso, S. I., Cereda, C., & Aguilera, A. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009260 · Cited by 104
Age and founder effect of SOD1 A4V mutation causing ALS
Saeed, M., Yang, Y., Deng, H.-X., Hung, W.-Y., Siddique, N. A., Dellefave‐Castillo, L. M., Gellera, C., Andersen, P. M., & Siddique, T. (2009) · Neurology · doi:10.1212/01.wnl.0000343509.76828.2a · Cited by 103
TDP-43, an ALS Linked Protein, Regulates Fat Deposition and Glucose Homeostasis
Stallings, N. R., Puttaparthi, K., Dowling, K. J., Luther, C. M., Burns, D. K., Davis, K. E., & Elliott, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071793 · Cited by 103
Braun, R. J., Sommer, C., Carmona‐Gutiérrez, D., Khoury, C. M., Ring, J., Büttner, S., & Madeo, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194852 · Cited by 103
Novel missense and truncating mutations in FUS/TLS in familial ALS
Waibel, S., Neumann, M., Rabe, M., Meyer, T., & Ludolph, A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f07e26 · Cited by 103
Freischmidt, A., Müller, K., Zondler, L., Weydt, P., Volk, A. E., Božič, A., Walter, M. J., von Bonin, M., Mayer, B., Arnim, C. A. F. V., et al. (2014) · Brain · doi:10.1093/brain/awu249 · Cited by 103
Coyne, A. N., Lorenzini, I., Chou, C., Torvund, M., Rogers, R. S., Starr, A., Zaepfel, B. L., Levy, J., Johannesmeyer, J., Schwartz, J. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.028 · Cited by 105
A fruitful endeavor: Modeling ALS in the fruit fly
Casci, I., & Pandey, U. B. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.064 · Cited by 102
microRNAs and Neurodegenerative Diseases
Qiu, L., Tan, E., & Zeng, L. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_6 · Cited by 102
Ebstein, S. Y., Yagudayeva, I., & Shneider, N. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.045 · Cited by 102
Metadata
- Authors
- Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., Baralle, F., de Belleroche, J., Mitchell, J. D., Leigh, P. N., Al-Chalabi, A., Miller, C. C., Nicholson, G., & Shaw, C. E.
- Affiliations
- The University of Sydney (AU)
- Department of Clinical Neuroscience, King's College London, Medical Research Council (MRC) Centre for Neurodegeneration Research, and Institute of Psychiatry, London, SE5 8AF, UK.
- Corresponding author
- Sreedharan, Jemeen
- Blair, Ian P.
- Tripathi, Vineeta B.
- Nicholson, Garth
- Shaw, Christopher E.
- ORCID
- Venue
- Science
- Published
- 2008-03-21
- Volume
- 319
- Issue
- 5870
- Pages
- 1668-1672
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7116650
- OpenAlex
- W1619082318
- Cited by
- 2,630
- References
- 29
- Citations by year
- 2026: 73 · 2025: 88 · 2024: 104 · 2023: 141 · 2022: 149 · 2021: 141 · 2020: 149 · 2019: 121 · 2018: 147 · 2017: 117 · 2016: 156 · 2015: 154 · 2014: 167 · 2013: 168 · 2012: 192
- FWCI
- 119.36
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Funders
- Wellcome Trust (076671)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, TDP-43, TARDBP, familial ALS, sporadic ALS, TDP-43 mutations, chromosome 1p36, genetic linkage, ubiquitinated inclusions, neurodegeneration, neuronal apoptosis, protein fragmentation
- MeSH terms
- Adult, Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Chick Embryo, Chromosomes, Human, Pair 1, Cricetulus, DNA-Binding Proteins, Female, Cricetinae, Humans, Male, Middle Aged, Molecular Sequence Data, Neurons, CHO Cells, Apoptosis, Microsatellite Repeats, Amino Acid Substitution, Mutation, Missense, Embryonic Development, Mutant Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
